Annual Total Assets
$382.00 M
-$225.40 M-37.11%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual total assets is $382.00 million, with the most recent change of -$225.40 million (-37.11%) on December 31, 2023.
- During the last 3 years, TBPH annual total assets has fallen by -$87.06 million (-18.56%).
- TBPH annual total assets is now -40.24% below its all-time high of $639.25 million, reached on December 31, 2016.
Performance
TBPH Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$356.11 M
-$5.92 M-1.64%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly total assets is $356.11 million, with the most recent change of -$5.92 million (-1.64%) on September 30, 2024.
- Over the past year, TBPH quarterly total assets has dropped by -$57.48 million (-13.90%).
- TBPH quarterly total assets is now -53.36% below its all-time high of $763.50 million, reached on September 30, 2022.
Performance
TBPH Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
TBPH Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.1% | -13.9% |
| 3 y3 years | -18.6% | -11.7% |
| 5 y5 years | -31.8% | -24.1% |
TBPH Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.1% | +1.9% | -53.4% | +0.2% |
| 5 y | 5-year | -37.1% | +1.9% | -53.4% | +0.2% |
| alltime | all time | -40.2% | +1417.3% | -53.4% | +1314.4% |
Theravance Biopharma Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $356.11 M(-1.6%) |
| Jun 2024 | - | $362.03 M(-2.5%) |
| Mar 2024 | - | $371.31 M(-2.8%) |
| Dec 2023 | $382.00 M(-37.1%) | $382.00 M(-7.6%) |
| Sep 2023 | - | $413.59 M(-7.4%) |
| Jun 2023 | - | $446.63 M(-17.1%) |
| Mar 2023 | - | $538.55 M(-11.3%) |
| Dec 2022 | $607.40 M(+62.1%) | $607.40 M(-20.4%) |
| Sep 2022 | - | $763.50 M(+111.6%) |
| Jun 2022 | - | $360.76 M(+1.5%) |
| Mar 2022 | - | $355.36 M(-5.2%) |
| Dec 2021 | $374.82 M(-20.1%) | $374.82 M(-7.0%) |
| Sep 2021 | - | $403.11 M(-6.1%) |
| Jun 2021 | - | $429.25 M(+14.4%) |
| Mar 2021 | - | $375.11 M(-20.0%) |
| Dec 2020 | $469.06 M(+14.7%) | $469.06 M(-8.4%) |
| Sep 2020 | - | $512.19 M(-9.2%) |
| Jun 2020 | - | $564.33 M(-6.8%) |
| Mar 2020 | - | $605.41 M(+48.1%) |
| Dec 2019 | $408.83 M | $408.83 M(-8.2%) |
| Sep 2019 | - | $445.34 M(-9.6%) |
| Jun 2019 | - | $492.45 M(-7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $531.26 M(-5.2%) |
| Dec 2018 | $560.24 M(+26.9%) | $560.24 M(+51.0%) |
| Sep 2018 | - | $370.96 M(-12.0%) |
| Jun 2018 | - | $421.36 M(-12.2%) |
| Mar 2018 | - | $480.11 M(+8.8%) |
| Dec 2017 | $441.40 M(-31.0%) | $441.40 M(-9.2%) |
| Sep 2017 | - | $486.16 M(-10.6%) |
| Jun 2017 | - | $543.89 M(-7.5%) |
| Mar 2017 | - | $588.04 M(-8.0%) |
| Dec 2016 | $639.25 M(+113.0%) | $639.25 M(+79.4%) |
| Sep 2016 | - | $356.29 M(-4.9%) |
| Jun 2016 | - | $374.49 M(+27.8%) |
| Mar 2016 | - | $293.13 M(-2.3%) |
| Dec 2015 | $300.12 M(-11.1%) | $300.12 M(+16.5%) |
| Sep 2015 | - | $257.51 M(-11.0%) |
| Jun 2015 | - | $289.48 M(-10.9%) |
| Mar 2015 | - | $324.90 M(-3.8%) |
| Dec 2014 | $337.77 M(+1241.6%) | $337.77 M(-11.5%) |
| Sep 2014 | - | $381.70 M(-11.4%) |
| Jun 2014 | - | $430.59 M(+1545.5%) |
| Mar 2014 | - | $26.17 M(+3.9%) |
| Dec 2013 | $25.18 M | $25.18 M |
FAQ
- What is Theravance Biopharma annual total assets?
- What is the all time high annual total assets for Theravance Biopharma?
- What is Theravance Biopharma annual total assets year-on-year change?
- What is Theravance Biopharma quarterly total assets?
- What is the all time high quarterly total assets for Theravance Biopharma?
- What is Theravance Biopharma quarterly total assets year-on-year change?
What is Theravance Biopharma annual total assets?
The current annual total assets of TBPH is $382.00 M
What is the all time high annual total assets for Theravance Biopharma?
Theravance Biopharma all-time high annual total assets is $639.25 M
What is Theravance Biopharma annual total assets year-on-year change?
Over the past year, TBPH annual total assets has changed by -$225.40 M (-37.11%)
What is Theravance Biopharma quarterly total assets?
The current quarterly total assets of TBPH is $356.11 M
What is the all time high quarterly total assets for Theravance Biopharma?
Theravance Biopharma all-time high quarterly total assets is $763.50 M
What is Theravance Biopharma quarterly total assets year-on-year change?
Over the past year, TBPH quarterly total assets has changed by -$57.48 M (-13.90%)